Perrigo to Release Third Quarter 2025 Financial Results on November 5, 2025

Rhea-AI Summary

Perrigo (NYSE: PRGO) announced it will release third quarter 2025 financial results on Wednesday, November 5, 2025 and host a conference call at 8:30 A.M. EST.

The call will stream live via webcast in the investor relations section at perrigo.investorroom.com/events-webcasts and is accessible by phone (US: 800-836-8184; International: 646-357-8785) with reference ID 03742. A taped replay will be available beginning ~12:00 P.M. EST on November 5 through midnight on November 12, 2025 (replay dial 888-660-6345 or International 646-517-4150; access code 03742#).

Company background: Perrigo is a self-care products company with leading store-brand and branded portfolios including Opill, Mederma, Compeed, EllaOne, and Jungle Formula.

DUBLIN, Oct. 22, 2025 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that it plans to issue its third quarter 2025 financial results on Wednesday, November 5^th, 2025, and host a conference call beginning at 8:30 A.M. (EST).

The earnings conference call will be available live via webcast to interested parties in the investor relations section of the Perrigo website at http://perrigo.investorroom.com/events-webcasts or by phone at 800-836-8184, International 646-357-8785, and reference ID # 03742. A taped replay of the call will be available beginning at approximately 12:00 P.M. (EST) Wednesday, November 5, until midnight Wednesday, November 12, 2025. To listen to the replay, dial 888-660-6345, International 646-517-4150, and use access code 03742#.

About Perrigo

Perrigo Company plc is a leading pure-play self-care company with over a century of experience in providing high-quality health and wellness solutions to consumers primarily in North America and Europe. As a pioneer in the over-the-counter (OTC) self-care market, Perrigo offers trusted self-care solutions that can be used without the need for a prescription, ensuring accessibility and choice for consumers across molecules, dosage forms, and value tiers.

Perrigo's unique business model leverages its complementary businesses, where cash-generative store brand private label offerings fuel investments for leading brands, including Opill^®, Mederma^®, Compeed^®, EllaOne^®, and Jungle Formula^®.

For more information, visit www.perrigo.com.

Forward-Looking Statements  

This press release includes, and the matters discussed in Perrigo's upcoming earnings release will include certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements involve known and unknown risks, uncertainties and other factors—many of which are beyond the Company's control—that may cause the actual results, performance or achievements of the Company to be materially different from its current expectations, assumptions, estimates and projections. Interested persons are urged to consult the Company's filings with the United States Securities and Exchange Commission, available at https://investor.perrigo.com/sec-filings, for a discussion of the Company's business and financial condition and certain material trends, risks, uncertainties and other factors relating thereto, including those discussed under "Risk Factors" in the Company's Form 10-K for the year ended December 31, 2024.

Perrigo Contact

Bradley Joseph, Vice President, Global Investor Relations & Corporate Communications, (269) 686-3373, E-mail: bradley.joseph@perrigo.com

Nicholas Gallagher, Associate Director, Global Investor Relations & Corporate Communications, (269) 686-3238, E-mail: nicholas.gallagher@perrigo.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/perrigo-to-release-third-quarter-2025-financial-results-on-november-5-2025-302590672.html

SOURCE Perrigo Company plc

FAQ

When will Perrigo (PRGO) release its Q3 2025 results?

Perrigo will release third quarter 2025 financial results on Wednesday, November 5, 2025.

What time is the Perrigo (PRGO) Q3 2025 earnings call on November 5, 2025?

The earnings conference call begins at 8:30 A.M. EST on November 5, 2025.

How can I listen to Perrigo's (PRGO) November 5, 2025 earnings webcast?

Listen live via webcast at perrigo.investorroom.com/events-webcasts or by phone US: 800-836-8184, International: 646-357-8785 (ref ID 03742).

When and how can I access the Perrigo (PRGO) earnings call replay for Q3 2025?

A taped replay is available from about 12:00 P.M. EST on November 5 until midnight on November 12, 2025; dial 888-660-6345 or International 646-517-4150 with access code 03742#.

Who should I contact for investor relations questions about Perrigo (PRGO)?

Investor relations contacts listed are Bradley Joseph, VP Global Investor Relations (269-686-3373) and Nicholas Gallagher, Associate Director (269-686-3238), with email contacts provided on the company site.